Myeloid Therapeutics

Myeloid Therapeutics is a biotechnology company that reprograms myeloid cells for treating cancers. It focuses on solid tumors and those that are poorly served by existing therapies. The company is presently advancing its cell therapy product candidates, derived from its ATAKTM platform technology.